PETS PetMed Express, Inc. - Common Stock
NASDAQ · Retail · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 13, 2026PETS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
PETS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O PetMed Express, Inc. - Common Stock Przegląd firmy z Wikipedii
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Business model
PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.
History
Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.
Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.
Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.
In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.
In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.
In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.
As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.
In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.
In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.
Recognition
The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.
== References ==
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | PETS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -1.0średnia z 5 lat ≈9.3 | ≈9.3 | · | · | |
| P/S (TTM) | 0.2średnia z 5 lat ≈0.3 | ≈0.3 | 0.2 | Wartość godziwa | |
| P/B (MRQ) | 1.3średnia z 5 lat ≈1.2 | ≈1.2 | · | · | |
| Cena / FCF (TTM) | -1.1średnia z 5 lat ≈-247.6 | ≈-247.6 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -1.2średnia z 5 lat ≈13.4 | ≈13.4 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 1.7średnia z 5 lat ≈2.2 | ≈2.2 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | PETS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 27.9%średnia z 5 lat ≈28.5% | ≈28.5% | 36.4% | Słaby | |
| Marża Operacyjna (TTM) | -18.2%średnia z 5 lat ≈-8.5% | ≈-8.5% | -1.3% | Słaby | |
| Marża EBITDA (TTM) | -12.7%średnia z 5 lat ≈-5.8% | ≈-5.8% | -1.3% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -17.4%średnia z 5 lat ≈-7.9% | ≈-7.9% | -2.0% | Słaby | |
| Marża Zysku Netto (TTM) | -17.3%średnia z 5 lat ≈-8.9% | ≈-8.9% | -2.0% | Słaby | |
| ROA (TTM) | -33.7%średnia z 5 lat ≈-19.4% | ≈-19.4% | -13.0% | Słaby | |
| ROE (TTM) | -78.6%średnia z 5 lat ≈-38.2% | ≈-38.2% | 12.9% | Słaby | |
| ROIC | -202.5%średnia z 5 lat ≈-77.2% | ≈-77.2% | -31.5% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | PETS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 0.7średnia z 5 lat ≈1.1 | ≈1.1 | 1.3 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.4średnia z 5 lat ≈0.7 | ≈0.7 | 0.3 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | PETS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -21.1%średnia z 5 lat ≈-9.2% | ≈-9.2% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -10.2%średnia z 5 lat ≈-6.5% | ≈-6.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -10.0% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | PETS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.6średnia z 5 lat ≈1.5 | ≈1.5 | 1.5 | Zgodnie z | |
| Receivables Turnover (Rotacja należności) | 84.7średnia z 5 lat ≈92.6 | ≈92.6 | 84.7 | Zgodnie z | |
| Revenue / Employee (Przychody / pracownika) | ≈$947.2K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Sie 11, 2023 | $0,30 | USD | ≈9.4% |
| Cze 5, 2023 | $0,30 | USD | ≈8.2% |
| Lut 16, 2023 | $0,30 | USD | ≈6.1% |
| Lis 17, 2022 | $0,30 | USD | ≈6.3% |
| Sie 11, 2022 | $0,30 | USD | ≈5.4% |
| Maj 19, 2022 | $0,30 | USD | ≈5.9% |
| Lut 4, 2022 | $0,30 | USD | ≈5.0% |
| Lis 5, 2021 | $0,30 | USD | ≈3.8% |
| Sie 5, 2021 | $0,30 | USD | ≈4.0% |
| Maj 13, 2021 | $0,30 | USD | ≈4.1% |
| Sty 29, 2021 | $0,28 | USD | ≈2.9% |
| Lis 6, 2020 | $0,28 | USD | ≈3.7% |
| Lip 30, 2020 | $0,28 | USD | ≈3.5% |
| Maj 14, 2020 | $0,28 | USD | ≈3.4% |
| Sty 31, 2020 | $0,27 | USD | ≈4.3% |
| Lis 1, 2019 | $0,27 | USD | ≈4.7% |
| Sie 1, 2019 | $0,27 | USD | ≈6.7% |
| Maj 16, 2019 | $0,27 | USD | ≈5.5% |
| Lut 1, 2019 | $0,27 | USD | ≈4.6% |
| Lis 2, 2018 | $0,27 | USD | ≈3.7% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 31 marca 2027 | Sie 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31 grudnia 2026 | Cze 2, 2026 | $-0.19 | $-0.18 | -3.5% |
| 30 czerwca 2026 | Sie 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31 marca 2026 | $-0.19 | $-0.18 | -3.5% | |
| 31 grudnia 2025 | $-0.50 | $-0.06 | -717.0% | |
| 30 czerwca 2025 | $-1.65 | $-0.07 | -2210.9% | |
| 31 marca 2025 | $-0.56 | $-0.05 | -1129.2% | |
| 31 grudnia 2024 | $-0.03 | $-0.01 | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | · | |
| Cost of Revenue | · | $158M | $189M | $171M | $195M | $219M | $203M | $188M | $176M | $170M | $158M | · | |
| Gross Profit | $50M | $69M | $85M | $77M | $77M | $84M | $81M | $95M | $98M | $79M | $76M | · | |
| SG&A Expense | $51M | $39M | $55M | $42M | $31M | $30M | $25M | $25M | $24M | $23M | $21M | · | |
| Operating Expenses | $109M | $71M | $93M | $70M | $53M | $54M | $50M | $49M | $46M | $42M | $44M | · | |
| Operating Income | $-59M | $-2M | $-8M | $6M | $24M | $31M | $31M | $46M | $52M | $37M | $32M | · | |
| Interest Income | · | · | · | $2M | $335.0K | $314.0K | $2M | $2M | $658.0K | $141.0K | $190.0K | · | |
| Other Non-op | $803.0K | $758.0K | $1M | $944.0K | $1M | $1M | $1M | $1M | $995.0K | $300.0K | $63.0K | · | |
| Pretax Income | $-57M | $-587.0K | $-6M | $7M | $24M | $31M | $34M | $49M | $54M | $38M | $33M | · | |
| Income Tax | $-73.0K | $6M | $1M | $2M | $5M | $7M | $8M | $11M | $17M | $14M | $12M | · | |
| Net Income | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | · | |
| EPS (Basic) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | · | |
| EPS (Diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | · | |
| Shares (Basic) | 20,921,361 | 20,596,022 | 20,395,959 | 20,274,786 | 20,175,930 | 20,060,000 | 20,041,000 | 20,461,000 | 20,346,000 | 20,232,000 | 20,124,000 | · | |
| Shares (Diluted) | 20,921,361 | 20,596,022 | 20,395,959 | 20,339,002 | 20,357,820 | 20,119,000 | 20,055,000 | 20,491,000 | 20,433,000 | 20,378,000 | 20,254,000 | · | |
| EBITDA | $-49M | $6M | $-1M | $6M | $26M | $38M | $31M | $46M | $52M | · | · | · |
Bilans
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $55M | $55M | $104M | $111M | $119M | $104M | $101M | $78M | $59M | $38M | $36M | |
| Receivables | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $3M | $2M | $2M | · | · | |
| Inventory | $14M | $16M | $29M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $5M | $6M | $5M | $5M | $5M | $4M | $1M | $882.0K | $1M | · | · | |
| Current Assets | $44M | $79M | $94M | $130M | $151M | $161M | $129M | $126M | $105M | $82M | · | · | |
| PP&E (Net) | $26M | $29M | $27M | $26M | $24M | $25M | $25M | $27M | $29M | $30M | · | · | |
| PP&E (Gross) | $58M | $54M | $47M | $41M | $36M | $36M | $36M | $36M | $35M | $34M | · | · | |
| Accum. Depreciation | $32M | $25M | $20M | $15M | $12M | $10M | $11M | $8M | $6M | $4M | · | · | |
| Goodwill | $0 | $27M | $27M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $8M | $11M | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | · | · | |
| Total Assets | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Accounts Payable | $21M | $24M | $37M | $25M | $28M | $40M | $20M | $16M | $15M | $15M | · | · | |
| Current Liabilities | $52M | $63M | $72M | $58M | $56M | $45M | $24M | $19M | $18M | $18M | · | · | |
| Capital Leases | $42.0K | $535.0K | $995.0K | $0 | · | · | · | · | · | · | · | · | |
| Deferred Tax | $175.0K | $263.0K | $0 | $3M | $0 | $1M | $970.0K | $1M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $52M | $64M | $73M | $58M | $56M | $46M | $25M | $20M | $19M | $19M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | $21.0K | $21.0K | $21.0K | · | · | |
| Paid-in Capital | $20M | $19M | $25M | $18M | $12M | $7M | $4M | $12M | $9M | $7M | · | · | |
| Retained Earnings | $9M | $67M | $72M | $92M | $112M | $134M | $126M | $122M | $106M | $87M | · | · | |
| Stockholders' Equity | $29M | $85M | $97M | $110M | $123M | $125M | $120M | $135M | $116M | $93M | $83M | $75M | |
| Liabilities + Equity | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Shares Outstanding | 21,385,638 | 20,657,000 | 21,148,000 | 21,084,000 | 20,979,000 | 20,269,000 | 20,166,000 | 20,674,000 | 20,601,000 | 20,526,000 | · | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $7M | $4M | $3M | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $-7M | $7M | $7M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | · | |
| Deferred Tax | $-88.0K | $5M | $292.0K | $-2M | $-846.0K | $-1M | $-151.0K | $125.0K | $-92.0K | $2M | $-23.0K | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $18M | $5M | $-2M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $5M | $4M | $28M | $18M | $40M | $39M | $45M | $37M | $47M | $21M | · | |
| CapEx | $5M | $5M | $5M | $5M | $2M | $2M | $2M | $620.0K | $703.0K | $11M | $20M | · | |
| Investing Cash Flow | $-5M | $-5M | $-41M | $-10M | $-2M | $-2M | $-2M | $-620.0K | $-703.0K | $-11M | $-4M | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $11M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $-11M | · | · | · | · | · | |
| Dividends Paid | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · | |
| Financing Cash Flow | $-299.0K | $-181.0K | $-12M | $-25M | $-24M | $-23M | $-33M | $-22M | $-17M | $-16M | $-15M | · | |
| Net Change in Cash | $-33M | $-576.0K | $-49M | $-7M | $-8M | $15M | $3M | $23M | $19M | $21M | $2M | · | |
| Taxes Paid | $52.0K | $525.0K | $130.0K | $4M | $6M | $10M | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | $-395.0K | $-194.0K | $23M | $17M | $38M | $37M | $45M | $37M | · | · | · |
Rentowność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.1% | 30.5% | 28.0% | 27.6% | 28.6% | 29.1% | · | · | 35.7% | · | · | · | |
| Operating Margin | -32.8% | -0.67% | -2.9% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| Net Margin | -32.0% | -2.8% | -2.7% | 2.0% | 7.7% | 9.9% | · | · | 13.6% | · | · | · | |
| Pretax Margin | -32.0% | -0.26% | -2.2% | 2.9% | 9.9% | 12.7% | · | · | 19.7% | · | · | · | |
| EBITDA Margin | -27.5% | 2.4% | -0.39% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| ROA | -49.8% | -3.9% | -4.4% | · | 11.6% | 17.8% | 16.7% | 26.1% | 30.1% | · | · | · | |
| ROE | -100.4% | -6.9% | -7.2% | · | 15.8% | 23.4% | 19.5% | 30.1% | 35.7% | · | · | · | |
| ROIC | -202.5% | -19.2% | -10.0% | · | 14.1% | 20.8% | 18.2% | 26.3% | 31.2% | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.3 | 1.3 | · | 4.5 | 3.6 | 5.3 | 6.8 | 5.8 | · | · | · | |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | 3.4 | 2.7 | 4.4 | 5.5 | 4.4 | · | · | · |
Efektywność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.4 | 1.7 | · | 1.5 | 1.8 | · | · | 2.2 | · | · | · | |
| Inventory Turnover | · | 7.1 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 84.7 | 81.1 | 111.9 | · | 121.5 | 96.2 | · | · | 133.6 | · | · | · |
Na akcję
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.35 | $4.12 | $4.57 | · | $6.78 | $6.97 | $6.45 | $6.51 | $5.62 | · | · | · | |
| Revenue / Share | $8.56 | $11.02 | $13.78 | $12.62 | $13.43 | $15.37 | · | · | $13.40 | · | · | · | |
| Cash Flow / Share | $-1.36 | $0.23 | $0.21 | $1.37 | $0.91 | $1.99 | $1.94 | $2.20 | $1.83 | · | · | · | |
| Cash / Share | $1.00 | $2.65 | $2.61 | · | $5.29 | $5.86 | $5.15 | $4.86 | $3.78 | · | · | · | |
| Dividend / Share | $0.00 | $0.00 | $0.60 | $1.20 | $1.20 | $1.12 | $1.08 | $1.06 | $0.85 | $0.76 | $0.72 | · | |
| EPS (TTM) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | $0.80 |
Stopy Wzrostu
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.1% | -17.2% | 10.7% | -9.1% | -10.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.2% | -5.9% | -3.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -72.8% | -22.7% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -72.5% | -21.8% | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -75.3% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | $227M | |
| Net Income TTM | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | $17M | |
| Market Cap | $49M | $87M | $101M | · | $541M | $713M | $580M | $471M | $860M | · | · | · | |
| P/E | -0.8 | -14.0 | -12.9 | 65.0 | 28.0 | 29.6 | 22.3 | 12.4 | 22.9 | 17.2 | 17.6 | 20.6 | |
| P/S | 0.3 | 0.4 | 0.4 | · | 2.0 | 2.3 | 2.0 | 1.7 | 3.1 | · | · | · | |
| P/B | 1.7 | 1.0 | 1.0 | · | 3.8 | 5.0 | 4.5 | 3.5 | 7.4 | · | · | · | |
| P / Tangible Book | 2.1 | 1.7 | 1.7 | 3.1 | 4.4 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.7 | 18.3 | 23.5 | · | 29.3 | 17.8 | 14.9 | 10.4 | 23.0 | · | · | · | |
| P / FCF | -1.5 | -219.1 | -522.2 | · | 32.3 | 18.9 | 15.9 | 10.6 | 23.5 | · | · | · | |
| Dividend Yield | 0.04% | 0.21% | 12.3% | · | 4.5% | 3.2% | 3.8% | 4.7% | 2.0% | · | · | · | |
| Earnings Yield | -120.2% | -7.2% | -7.7% | 1.5% | 3.6% | 3.4% | 4.5% | 8.1% | 4.4% | 5.8% | 5.7% | 4.8% | |
| Payout Ratio | -0.04% | -2.9% | -166.6% | 477.4% | 115.6% | 74.1% | 84.3% | 58.1% | 46.9% | · | · | · | |
| Annual Payout | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $43M | $41M | $44M | $51M | $51M | $52M | $58M | $66M | $60M | $64M | $69M | $76M | $53M | $57M | $63M | |
| Cost of Revenue | $30M | · | · | $32M | $37M | $36M | $36M | $39M | $47M | $35M | $44M | $48M | $51M | $30M | $41M | $43M | |
| Gross Profit | $11M | $14M | $9M | $12M | $14M | $15M | $16M | $19M | $19M | $24M | $19M | $21M | $25M | $23M | $17M | $20M | |
| SG&A Expense | $11M | $11M | $12M | $14M | $13M | $12M | $11M | $10M | $5M | $14M | $13M | $12M | $16M | $12M | $10M | $10M | |
| Operating Expenses | $18M | $20M | $20M | $21M | $49M | $21M | $17M | $18M | $15M | $28M | $22M | $20M | $27M | $23M | $17M | $17M | |
| Operating Income | $-6M | $-6M | $-10M | $-8M | $-34M | $-6M | $-450.0K | $554.0K | $4M | $-4M | $-3M | $875.0K | $-2M | $-212.0K | $-769.0K | $4M | |
| Interest Income | $100.0K | · | $200.0K | · | $300.0K | · | $500.0K | · | · | · | · | $570.0K | $620.0K | · | $708.0K | $388.0K | |
| Other Non-op | $438.0K | $273.0K | $148.0K | $195.0K | $187.0K | $161.0K | $180.0K | $186.0K | $231.0K | $325.0K | $293.0K | $254.0K | $506.0K | $226.0K | $259.0K | $261.0K | |
| Pretax Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-6M | $-242.0K | $925.0K | $5M | $-3M | $-3M | $1M | $-1M | $453.0K | $-211.0K | $4M | |
| Income Tax | $13.0K | $-102.0K | $11.0K | $9.0K | $9.0K | $6M | $465.0K | $-1M | $958.0K | $2M | $-618.0K | $565.0K | $-292.0K | $669.0K | $1.0K | $1M | |
| Net Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-12M | $-707.0K | $2M | $4M | $-5M | $-2M | $715.0K | $-1M | $-216.0K | $-212.0K | $3M | |
| EPS (Basic) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.25 | $-0.10 | $0.04 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| EPS (Diluted) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.24 | $-0.10 | $0.03 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| Shares (Basic) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,597,807 | 20,513,281 | · | 20,425,282 | 20,382,979 | 20,332,526 | · | 20,301,384 | 20,261,114 | |
| Shares (Diluted) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,938,817 | 20,941,505 | · | 20,425,282 | 20,780,455 | 20,332,526 | · | 20,301,384 | 20,343,980 | |
| EBITDA | $-4M | · | $-8M | $-6M | $-32M | · | $1M | $2M | $6M | · | $-1M | $3M | $-450.0K | · | $-769.0K | $3M |
Bilans
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $21M | $27M | $36M | $41M | $55M | $50M | $52M | $46M | $55M | $49M | $53M | $62M | · | $102M | $97M | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | · | $2M | $2M | |
| Inventory | $8M | $14M | $12M | $15M | $18M | $16M | $12M | $13M | · | $29M | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $8M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | $9M | $10M | $9M | · | $6M | $5M | |
| Current Assets | $28M | $44M | $49M | $59M | $68M | $79M | $68M | $71M | $78M | $94M | $96M | $85M | $105M | · | $134M | $138M | |
| PP&E (Net) | $25M | $26M | $28M | $28M | $29M | $29M | $28M | $26M | $26M | $27M | $27M | $27M | $27M | · | $25M | $25M | |
| PP&E (Gross) | · | $58M | · | · | · | $54M | · | · | · | $47M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $32M | · | · | · | $25M | · | · | · | $20M | · | · | · | · | · | · | |
| Goodwill | · | $0 | $0 | $0 | $0 | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | · | · | |
| Intangibles | $5M | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | · | · | · | |
| Total Assets | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Accounts Payable | $12M | $21M | $20M | $19M | $20M | $24M | $11M | $17M | $24M | $37M | $39M | $25M | $40M | · | $24M | $24M | |
| Current Liabilities | $41M | $52M | $55M | $57M | $58M | $63M | $48M | $49M | $58M | $72M | $72M | $61M | $79M | · | $31M | $31M | |
| Capital Leases | $0 | $42.0K | $167.0K | $291.0K | $414.0K | $535.0K | $652.0K | $768.0K | $883.0K | $995.0K | $890.0K | $1M | $1M | · | · | · | |
| Deferred Tax | $175.0K | $175.0K | $263.0K | $263.0K | $263.0K | $263.0K | · | · | · | $0 | · | · | $0 | · | $465.0K | $547.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | |
| Total Liabilities | $41M | $52M | $55M | $57M | $58M | $64M | $49M | $50M | $59M | $73M | $73M | $62M | $80M | · | $32M | $31M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | $21.0K | $21.0K | |
| Paid-in Capital | $20M | $20M | $19M | $19M | $19M | $19M | $18M | $18M | $17M | $25M | $23M | $22M | $20M | · | $17M | $15M | |
| Retained Earnings | $3M | $9M | $13M | $24M | $32M | $67M | $78M | $79M | $77M | $72M | $77M | $79M | $84M | · | $117M | $123M | |
| Stockholders' Equity | $23M | $29M | $33M | $43M | $52M | $85M | $96M | $96M | $94M | $97M | $100M | $100M | $104M | $110M | $134M | $138M | |
| Liabilities + Equity | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Shares Outstanding | 21,682,381 | 21,385,638 | 21,382,521 | 21,015,559 | 20,835,210 | 20,656,822 | 20,656,457 | 20,663,218 | 20,600,652 | 21,148,000 | 21,160,739 | 21,147,006 | 21,170,000 | 21,084,000 | 21,077,000 | 21,077,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $994.0K | $941.0K | $858.0K | |
| Stock-based Comp | $198.0K | $274.0K | $300.0K | $200.0K | $591.0K | $518.0K | $500.0K | $600.0K | $-8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | $-88.0K | $0 | $0 | $0 | $5M | $465.0K | $-670.0K | $-26.0K | $728.0K | $-355.0K | $304.0K | $-627.0K | $-516.0K | $-725.0K | $-521.0K | |
| Amort. of Intangibles | $200.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $0 | $0 | $0 | |
| Other Non-cash | $-4M | · | · | · | $19M | · | · | · | $-6M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-8M | $-5M | $-9M | $-2M | $-12M | $7M | $-1M | $7M | $-9M | $7M | $-3M | $-777.0K | $562.0K | $10M | $13M | $-1M | |
| CapEx | $641.0K | $720.0K | $-21.0K | $3M | $1M | $2M | $777.0K | $1M | $683.0K | $1M | $1M | $984.0K | $1M | $2M | $993.0K | $1M | |
| Investing Cash Flow | $-641.0K | $-720.0K | $21.0K | $-3M | $-1M | $-2M | $-777.0K | $-1M | $-683.0K | $-1M | $-1M | $-984.0K | $-37M | $-2M | $-993.0K | $-1M | |
| Dividends Paid | $0 | $-3.0K | $1.0K | $22.0K | $1.0K | $5.0K | $1.0K | $71.0K | $104.0K | $18.0K | $15.0K | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-5.0K | $-38.0K | $0 | $-231.0K | $-30.0K | $-5.0K | $-1.0K | $-71.0K | $-104.0K | $-18.0K | $-15.0K | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Net Change in Cash | $-8M | $-6M | $-9M | $-5M | $-14M | $5M | $-2M | $6M | $-9M | $6M | $-4M | $-8M | $-43M | $2M | $6M | $-9M | |
| Taxes Paid | $-120.0K | $-22.0K | $8.0K | $70.0K | $-4.0K | $51.0K | $8.0K | $385.0K | $81.0K | $87.0K | $43.0K | $0 | $0 | $442.0K | $1M | · | |
| Free Cash Flow | $-8M | · | · | · | $-14M | · | · | · | $-9M | · | · | · | $-591.0K | · | · | · |
Rentowność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.6% | · | 23.3% | 28.0% | 28.1% | · | 28.1% | 29.1% | 26.5% | · | 27.4% | 28.3% | 28.8% | · | 25.9% | 28.2% | |
| Operating Margin | -15.2% | · | -25.8% | -18.9% | -66.7% | · | -0.85% | 0.93% | 6.5% | · | -4.7% | 1.2% | -2.7% | · | -1.3% | 4.5% | |
| Net Margin | -15.0% | · | -25.9% | -19.2% | -66.7% | · | -1.3% | 3.9% | 5.5% | · | -3.1% | 1.0% | -1.5% | · | -0.03% | 3.9% | |
| Pretax Margin | -14.9% | · | -25.9% | -19.2% | -66.7% | · | -0.46% | 1.6% | 6.9% | · | -4.0% | 1.8% | -1.8% | · | 0.34% | 5.5% | |
| EBITDA Margin | -10.0% | · | -19.9% | -13.8% | -62.2% | · | 2.1% | 3.7% | 9.0% | · | -2.0% | 3.6% | -0.58% | · | -1.3% | 4.5% | |
| ROA | -7.1% | · | -9.1% | -6.9% | -26.0% | · | -0.44% | 1.5% | 2.2% | · | -1.2% | 0.43% | -0.65% | · | -0.01% | 1.6% | |
| ROE | -16.5% | · | -16.4% | -12.2% | -47.1% | · | -0.72% | 2.4% | 3.8% | · | -1.7% | 0.60% | -0.93% | · | -0.01% | 1.8% | |
| ROIC | -27.2% | · | -32.0% | -19.5% | -66.2% | · | -1.4% | 1.4% | 3.7% | · | -2.4% | 0.49% | -1.6% | · | 0.06% | 1.5% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | · | 0.9 | 1.0 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 4.3 | 4.5 | |
| Quick Ratio | 0.4 | · | 0.5 | 0.7 | 0.7 | · | 1.1 | 1.1 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 3.4 | 3.2 |
Efektywność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | 2.2 | · | · | 2.3 | 4.0 | · | 6.5 | 6.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 24.8 | · | 21.3 | 24.7 | 26.5 | · | 25.3 | 31.4 | 32.7 | · | 33.7 | 37.7 | 42.6 | · | 36.7 | 38.0 |
Na akcję
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.06 | · | $1.53 | $2.05 | $2.47 | · | $4.66 | $4.67 | $4.54 | · | $4.73 | $4.75 | $4.92 | · | $6.34 | $6.55 | |
| Revenue / Share | $1.89 | · | $1.94 | $2.12 | $2.47 | · | $2.57 | $2.85 | $3.24 | · | $3.20 | $3.42 | $3.85 | · | $2.90 | $3.21 | |
| Cash Flow / Share | $-0.35 | · | · | · | $-0.59 | · | · | · | $-0.41 | · | · | · | $0.03 | · | · | · | |
| Cash / Share | $0.60 | · | $1.26 | $1.72 | $1.97 | · | $2.43 | $2.52 | $2.23 | · | $2.34 | $2.53 | $2.91 | · | $4.86 | $4.58 | |
| Dividend / Share | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | |
| EPS (TTM) | $-1.37 | · | $-3.12 | $-2.65 | $-2.13 | · | $0.02 | $-0.05 | $-0.13 | · | $-0.14 | $-0.05 | $0.06 | · | $0.44 | $0.66 |
Wycena (TTM)
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $169M | · | $187M | $198M | $212M | · | $236M | $247M | $259M | · | $262M | $256M | $250M | · | $253M | $256M | |
| Net Income TTM | $-29M | · | $-65M | $-55M | $-44M | · | $357.0K | $-963.0K | $-3M | · | $-3M | $-849.0K | $1M | · | $9M | $13M | |
| Market Cap | $42M | · | $68M | $53M | $69M | · | $100M | $76M | $83M | · | $160M | $217M | $292M | · | $373M | $411M | |
| P/E | -1.4 | · | -1.0 | -0.9 | -1.6 | · | 241.0 | -73.6 | -31.2 | · | -54.0 | -205.0 | 229.8 | · | 40.2 | 29.6 | |
| P/S | 0.2 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.6 | 0.8 | 1.2 | · | 1.5 | 1.6 | |
| P/B | 1.8 | · | 2.1 | 1.2 | 1.3 | · | 1.0 | 0.8 | 0.9 | · | 1.6 | 2.2 | 2.8 | · | 2.8 | 3.0 | |
| P / Tangible Book | 2.3 | · | 2.6 | 1.4 | 1.6 | · | 1.7 | 1.3 | 1.5 | · | 2.6 | 3.5 | 4.5 | · | 2.8 | 3.0 | |
| P / Cash Flow | -5.4 | · | · | · | -5.6 | · | · | · | -9.8 | · | · | · | 519.5 | · | · | · | |
| Dividend Yield | 0.05% | · | 0.04% | 0.05% | 0.11% | · | 0.19% | 0.27% | 7.8% | · | 11.8% | 11.5% | 8.5% | · | 6.6% | 5.9% | |
| Earnings Yield | -71.4% | · | -97.5% | -105.6% | -64.2% | · | 0.41% | -1.4% | -3.2% | · | -1.8% | -0.49% | 0.44% | · | 2.5% | 3.4% | |
| Payout Ratio | 0.00% | · | · | · | 0.00% | · | · | · | 2.8% | · | · | · | -537.1% | · | · | · | |
| Annual Payout | $20.0K | · | $29.0K | $29.0K | $78.0K | · | $194.0K | $208.0K | $6M | · | $19M | $25M | $25M | · | $24M | $24M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Przychody | $179M | $227M | $274M | $248M | · |
| Marża Brutto % | 28.1% | 30.5% | 28.0% | 27.6% | · |
| Marża Operacyjna % | -32.8% | -0.67% | -2.9% | 2.4% | · |
| Zysk netto | $-57M | $-6M | $-7M | $5M | · |
| Rozwodniony EPS | $-2.74 | $-0.30 | $-0.37 | $0.25 | · |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 0.8 | 1.3 | 1.3 | · | · |
| Wskaźnik Szybkości | 0.4 | 0.9 | 0.8 | · | · |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-33M | $-395.0K | $-194.0K | $23M | · |
Właściciele instytucjonalni (13F) 53 emitenci · $11.9M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 10 (0 vs poprzedni kw.) | 8 (-2 vs poprzedni kw.) | 9 (-1 vs poprzedni kw.) | 18 (+2 vs poprzedni kw.) | -1.3M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3 084 028 | 963 759 | 26,00% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $2 171 962 | 1 131 230 | 18,31% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 588 602 | 827 397 | 13,39% | Akcje |
| BlackRock, Inc. | $1 091 050 | 568 255 | 9,20% | Akcje |
| FEDERATED HERMES, INC. | $407 367 | 212 170 | 3,43% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $391 947 | 204 075 | 3,30% | Akcje |
| STEEL PARTNERS HOLDINGS L.P. | $371 835 | 193 664 | 3,13% | Akcje |
| UBS Group AG | $265 594 | 138 330 | 2,24% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232 412 | 121 048 | 1,96% | Akcje |
| Rangeley Capital, LLC | $232 320 | 121 000 | 1,96% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $212 124 | 110 481 | 1,79% | Akcje |
| STATE STREET CORP | $201 932 | 105 173 | 1,70% | Akcje |
| Formidable Asset Management, LLC | $195 056 | 85 551 | 1,64% | Akcje |
| Empowered Funds, LLC | $158 108 | 82 348 | 1,33% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $156 301 | 81 407 | 1,32% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $152 646 | 79 503 | 1,29% | Akcje |
| CITADEL ADVISORS LLC | $142 324 | 74 127 | 1,20% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $115 811 | 60 353 | 0,98% | Akcje |
| UMB Bank, n.a. | $115 200 | 60 000 | 0,97% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $91 647 | 47 733 | 0,77% | Akcje |
| NORTHERN TRUST CORP | $81 893 | 42 653 | 0,69% | Akcje |
| XTX Topco Ltd | $80 511 | 41 933 | 0,68% | Akcje |
| CIBC Private Wealth Group LLC | $75 300 | 30 000 | 0,63% | Akcje |
| SIMPLEX TRADING, LLC | $47 702 | 24 845 | 0,40% | Akcje |
| IMC-Chicago, LLC | $44 014 | 22 924 | 0,37% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $29 568 | 15 400 | 0,25% | Opcja kupna |
| Jain Global LLC | $26 148 | 13 619 | 0,22% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $24 712 | 12 871 | 0,21% | Akcje |
| MORGAN STANLEY | $22 282 | 11 604 | 0,19% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $17 637 | 9 186 | 0,15% | Akcje |
| Vanguard Global Advisers, LLC | $15 590 | 8 120 | 0,13% | Akcje |
| OSAIC HOLDINGS, INC. | $6 772 | 3 527 | 0,06% | Akcje |
| SBI Securities Co., Ltd. | $2 148 | 1 119 | 0,02% | Akcje |
| Bank & Trust Co | $2 054 | 901 | 0,02% | Akcje |
| HARBOUR INVESTMENTS, INC. | $1 037 | 540 | 0,01% | Akcje |
| Accredited Wealth Management, LLC | $1 004 | 5 636 | 0,01% | Akcje |
| Allworth Financial LP | $949 | 494 | 0,01% | Akcje |
| MCF Advisors LLC | $768 | 400 | 0,01% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $730 | 415 | 0,01% | Akcje |
| Ascentis Independent Advisors | $683 | 356 | 0,01% | Akcje |
| WELLS FARGO & COMPANY/MN | $577 | 300 | 0,00% | Akcje |
| ROTHSCHILD INVESTMENT LLC | $480 | 250 | 0,00% | Akcje |
| Tower Research Capital LLC (TRC) | $323 | 168 | 0,00% | Akcje |
| Farther Finance Advisors, LLC | $290 | 151 | 0,00% | Akcje |
| PRICE T ROWE ASSOCIATES INC /MD/ | $250 | 129 933 | 0,00% | Akcje |
| FMR LLC | $115 | 60 | 0,00% | Akcje |
| Elevated Capital Advisors, LLC | $96 | 50 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $23 | 12 | 0,00% | Akcje |
| CITIGROUP INC | $17 | 9 | 0,00% | Akcje |
| CoreCap Advisors, LLC | $8 | 4 | 0,00% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| SilverCape Investments Limited, Peter Kennedy ×3 zgłoszenia | 29 czerwca 2026 | 12,07% | Aneks | Inwestycja pasywna | SEC |
| Diveroli Investment Group LLC, Kingbird Ventures LLC | 11 lutego 2026 | 1,83% | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 29 insiderów · 8 dyrektorzy generalni · 16 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jeffrey Allen Willard | CEO and President | 28 września 2026 A | 250 000 | 0 | 0 | $0 |
| Leslie C.G. Campbell | Interim CEO and President | 11 sierpnia 2026 A | 145 000 | 0 | 0 | $0 |
| Sandra Yvette Campos | CEO & President | 30 kwietnia 2025 S | 578 524 | 0 | 0 | $0 |
| Menderes Akdag | CEO & President | 27 stycznia 2021 S | 337 800 | 0 | 0 | $0 |
| Douglas Krulik | CAO and Interim CFO | 26 czerwca 2026 A | 102 500 | 0 | 0 | $0 |
| Robyn M. D'Elia | Chief Financial Officer | 27 września 2024 A | 250 000 | 0 | 0 | $0 |
| Christine Chambers | CFO | 31 maja 2024 D | 65 146 | 0 | 0 | $0 |
| Bruce S Rosenbloom | Chief Financial Officer | 30 lipca 2021 A | 45 450 | 0 | 0 | $0 |
| Tamar Elkeles | Dyrektor | 17 września 2026 A | 49 923 | 0 | 0 | $0 |
| Peter Batushansky | Dyrektor | 11 sierpnia 2026 A | 91 928 | 0 | 0 | $0 |
| Justin L. Mennen | Dyrektor | 11 sierpnia 2026 A | 98 274 | 0 | 0 | $0 |
| Gian Fulgoni | Dyrektor | 21 stycznia 2026 D | 132 299 | 0 | 0 | $0 |
| Leah Solivan | Dyrektor | 30 października 2025 A | 42 289 | 0 | 0 | $0 |
| Diana G Purcel | Dyrektor | 8 sierpnia 2024 A | 24 375 | 0 | 0 | $0 |
| Jodi Watson | Dyrektor | 28 lipca 2022 A | 18 880 | 0 | 0 | $0 |
| Peter Cobb | Dyrektor | 28 lipca 2022 A | 15 000 | 0 | 0 | $0 |
| Ronald J Korn | Dyrektor | 30 lipca 2021 A | 90 833 | 0 | 0 | $0 |
| Frank J Formica | Dyrektor | 29 stycznia 2021 S | 55 000 | 0 | 0 | $0 |
| Robert C Schweitzer | Dyrektor | 28 sierpnia 2020 S | 95 834 | 0 | 0 | $0 |
| Marc Puleo MD | Dyrektor | 16 sierpnia 2005 J | 913 286 | 0 | 0 | $0 |
| SilverCape Investments Limited | Posiadacz 10% | 13 sierpnia 2025 P | 2 579 696 | 0 | 0 | $0 |
| TRICON HOLDINGS LLC | Posiadacz 10% | 4 sierpnia 2006 S | 2 284 000 | 0 | 0 | $0 |
| James Lacamp | · | 11 sierpnia 2026 A | 90 421 | 0 | 0 | $0 |
| Jacqueline Paula Smith | · | 15 stycznia 2025 A | 28 099 | 0 | 0 | $0 |
| Mathew N Hulett | · | 29 kwietnia 2024 D | 103 850 | 0 | 0 | $0 |
| Mark Bradley Moseley JR | · | 11 grudnia 2023 A | 42 000 | 0 | 0 | $0 |
| Daniel Job Pingree | · | 17 maja 2023 A | 22 000 | 0 | 0 | $0 |
| CRESLIN LTD | · | 4 sierpnia 2006 S | 2 284 000 | 0 | 0 | $0 |
| Guven Kivilcim | · | 22 stycznia 2004 S | 1 310 300 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 20 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| EWUS · iShares Trust | 0,25% | 37 222 SH | 11 września 2026 | Dziennie |
| ISVL · iShares Trust | 0,17% | 202 554 SH | 11 września 2026 | Dziennie |
| ISCF · iShares Trust | 0,09% | 216 018 SH | 11 września 2026 | Dziennie |
| IEUS · iShares Trust | 0,07% | 45 419 SH | 11 września 2026 | Dziennie |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,05% | 58 613 SH | 2 października 2026 | Dziennie |
| SCZ · iShares Trust | 0,03% | 1 496 647 SH | 11 września 2026 | Dziennie |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 1 566 925 SH | 19 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,01% | 26 193 SH | 11 września 2026 | Dziennie |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 1 056 528 SH | 19 sierpnia 2026 | Dziennie |
| IEUR · iShares Trust | 0,01% | 291 699 SH | 11 września 2026 | Dziennie |
| IWC · iShares Trust | 0,01% | 51 213 SH | 11 września 2026 | Dziennie |
| IEFA · iShares Trust | 0,00% | 3 372 753 SH | 11 września 2026 | Dziennie |
| IDEV · iShares Trust | 0,00% | 546 389 SH | 11 września 2026 | Dziennie |
| IXUS · iShares Trust | 0,00% | 684 652 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 211 088 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 602 795 SH | 19 sierpnia 2026 | Dziennie |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 6 557 275 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 341 189 SH | 19 sierpnia 2026 | Dziennie |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 4 366 658 SH | 19 sierpnia 2026 | Dziennie |
| VSGX · VANGUARD WORLD FUND | 0,00% | 78 854 SH | 19 sierpnia 2026 | Dziennie |
PETS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
1 analityków · 2026-10-01Średnia cel $1.40 +2,9%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| PETS | $49M | -0.8 | -21.1% | -32.0% | -100.4% | 28.1% |
| RENT | · | 3.7 | 7.7% | 6.9% | -16.9% | · |
| GROV | $46M | -3.2 | -14.6% | -6.7% | 75.6% | 53.7% |
| SPWH | $52M | -1.1 | 0.96% | -4.1% | -25.2% | 30.9% |
| LESL | $46M | -0.2 | -6.6% | -19.1% | 70.0% | 35.4% |
| ULTA | $27.83B | 24.6 | 9.7% | 9.3% | 42.7% | 39.1% |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.